https://de.marketscreener.com/kurs/aktie/ACER-THERAPEUTICS-INC-37866676/news/Acer-Therapeutics-gibt-die-vollstandige-Rekrutierung-der-Phase-2A-Studie-mit-Acer-801-Osanetant-z-42994137/?utm_source=telegram&utm_medium=social&utm_campaign=share